To improve health in our therapeutic areas of expertise through clinical research that is deeply rooted in medicine.
Science. Networks. Delivery.
Who we are
P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.
Where we come from
Julius Clinical was founded in 2008 as a spin-off from UMC Utrecht, built on a strong academic foundation and a commitment to advancing science through clinical research.
Today, that foundation is even stronger. Through our merger with P95, we have combined Julius Clinical’s expertise in global clinical development with P95’s leadership in epidemiology, vaccines, infectious diseases, and real-world evidence. Together, we form a science-led global CRO with more than 500 professionals across 25+ countries.
Our approach remains rooted in scientific rigor and close collaboration with internationally recognized experts, enabling P95 Julius Clinical to deliver high-quality research that advances innovation and improves health worldwide.
What we do
Science is what we do.
P95 Julius Clinical specialises in well-defined areas to constantly expand on our delivery and scientific collaborations in those areas. That is how we make a difference in the world of clinical trials.
Who we are
P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.
Where we come from
Julius Clinical was founded in 2008 as a spin-off from UMC Utrecht, built on a strong academic foundation and a commitment to advancing science through clinical research.
Today, that foundation is even stronger. Through our merger with P95, we have combined Julius Clinical’s expertise in global clinical development with P95’s leadership in epidemiology, vaccines, infectious diseases, and real-world evidence. Together, we form a science-led global CRO with more than 500 professionals across 25+ countries.
Our approach remains rooted in scientific rigor and close collaboration with internationally recognized experts, enabling P95 Julius Clinical to deliver high-quality research that advances innovation and improves health worldwide.
What we do
Science is what we do.
P95 Julius Clinical specialises in well-defined areas to constantly expand on our delivery and scientific collaborations in those areas. That is how we make a difference in the world of clinical trials.
Our unique triangle
To be the role model for and the market leader in the clinical research industry. We will do this by focusing on our core strengths:
- Providing independent, innovative, and high-quality clinical services to our clients and scientific institutions
- Responding to the challenges of the pharmaceutical industry by delivering scientifically credible, creative, and tailor-made alternatives for current clinical research practices
- Developing and publishing clinical research on innovative products that impact medicine
Surprising
We do things differently. With our scientific approach and surprisingly customer-centric culture, we deliver the best possible study experience for Sponsors. Don’t be surprised if we don’t suggest the obvious. We exceed expectations and make a difference in our well-defined therapeutic focus areas.
Flexible
We work in a dynamic market. Every day we need to adapt to meet the expectations of our clients. Our flexibility and imagination help us find best-fit solutions that meet or exceed industry standards for quality.
Passionate
We bring a passionate approach to a business environment. With relentless dedication, a deep well of energy, and entrepreneurial drive, we commit ourselves to tailor-made clinical trials that impact lives around the world.
Best in class
We were founded with a strong scientific foundation, and we use science to support sponsors in defining and achieving their medical endpoints. We combine this with our entrepreneurial mindset to become a leading service provider in conducting global clinical trials in well-defined therapeutic areas.
Trustworthy
We are well-positioned as a trustworthy clinical research partner because of our scientific and medical knowledge, highly qualified employees, strong relationships with leading experts, and access to global research networks. As a result, we have a strong track record of high-quality, innovative, and tailor-made clinical trials within our well-defined therapeutic areas.
Engaged employer
We are a Dutch company with an open and direct — but warm — culture. Combined with our many colleagues around the world, we look after each other and place great importance on collaboration and cooperation. This culture drives us to perform at our best every day.
Key Opinion Leaders
At P95 Julius Clinical, we are committed to delivering the highest level of expertise in every therapeutic area we cover. By collaborating closely with key opinion leaders, we ensure that our research and clinical trials are guided by the most current and comprehensive knowledge available. This partnership allows us to offer unparalleled insights and innovative solutions, ultimately advancing healthcare and improving patient outcomes.
